Dyadic International Inc
DYAI1.000USD
+0.090+9.89%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
36.18MMarket Cap
LossP/E TTM
More Details of Dyadic International Inc Company
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.
Dyadic International Inc Info
Ticker SymbolDYAI
Company nameDyadic International Inc
IPO dateNov 05, 2004
CEOEmalfarb (Mark A)
Number of employees6
Security typeOrdinary Share
Fiscal year-endNov 05
Address1044 North U.S. Highway One
CityJUPITER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33477
Phone15617438333
Websitehttps://dyadic.com/
Ticker SymbolDYAI
IPO dateNov 05, 2004
CEOEmalfarb (Mark A)
Company Executives of Dyadic International Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Mark A. Emalfarb
Mr. Mark A. Emalfarb
Chief Executive Officer, Director
Chief Executive Officer, Director
4.73M
--
Ms. Ping Wang Rawson, CPA
Ms. Ping Wang Rawson, CPA
Chief Financial Officer
Chief Financial Officer
140.99K
--
Mr. Patrick K. Lucy
Mr. Patrick K. Lucy
Independent Chairman of the Board
Independent Chairman of the Board
50.76K
--
Dr. Ronen Tchelet, Ph.D.
Dr. Ronen Tchelet, Ph.D.
Vice President - Research and Business Development
Vice President - Research and Business Development
32.83K
+37.65%
Dr. Seth J. Herbst, M.D.
Dr. Seth J. Herbst, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Hazelton
Mr. Joseph (Joe) Hazelton
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Mr. Jack L. Kaye, CPA
Mr. Jack L. Kaye, CPA
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Mark A. Emalfarb
Mr. Mark A. Emalfarb
Chief Executive Officer, Director
Chief Executive Officer, Director
4.73M
--
Ms. Ping Wang Rawson, CPA
Ms. Ping Wang Rawson, CPA
Chief Financial Officer
Chief Financial Officer
140.99K
--
Mr. Patrick K. Lucy
Mr. Patrick K. Lucy
Independent Chairman of the Board
Independent Chairman of the Board
50.76K
--
Dr. Ronen Tchelet, Ph.D.
Dr. Ronen Tchelet, Ph.D.
Vice President - Research and Business Development
Vice President - Research and Business Development
32.83K
+37.65%
Dr. Seth J. Herbst, M.D.
Dr. Seth J. Herbst, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Hazelton
Mr. Joseph (Joe) Hazelton
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Emalfarb (Mark A)
13.07%
Francisco Trust
9.42%
Apis Capital Advisors LLC
4.26%
Chapin Davis Asset Management
2.58%
The Vanguard Group, Inc.
2.53%
Other
68.14%
Shareholders
Shareholders
Proportion
Emalfarb (Mark A)
13.07%
Francisco Trust
9.42%
Apis Capital Advisors LLC
4.26%
Chapin Davis Asset Management
2.58%
The Vanguard Group, Inc.
2.53%
Other
68.14%
Shareholder Types
Shareholders
Proportion
Individual Investor
15.84%
Corporation
9.42%
Investment Advisor
9.03%
Hedge Fund
5.29%
Investment Advisor/Hedge Fund
1.74%
Bank and Trust
0.93%
Venture Capital
0.07%
Research Firm
0.06%
Other
57.62%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
67
6.19M
14.14%
--
2025Q3
69
6.19M
14.21%
+1.17M
2025Q2
67
5.02M
17.34%
-34.61K
2025Q1
64
5.06M
17.41%
-179.68K
2024Q4
66
5.12M
16.50%
+343.55K
2024Q3
64
4.78M
17.00%
+94.58K
2024Q2
63
4.69M
16.54%
+162.98K
2024Q1
59
4.53M
16.61%
-322.18K
2023Q4
60
4.51M
16.85%
+7.33K
2023Q3
68
4.51M
17.97%
-1.09K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Emalfarb (Mark A)
4.73M
13.07%
--
--
Apr 24, 2025
Francisco Trust
3.41M
9.42%
--
--
Apr 24, 2025
Chapin Davis Asset Management
882.85K
2.44%
+40.00K
+4.75%
Jun 30, 2025
The Vanguard Group, Inc.
860.66K
2.38%
+46.32K
+5.69%
Jun 30, 2025
Truist Bank
250.00K
0.69%
--
--
Jun 30, 2025
Tarnok (Michael P)
281.03K
0.78%
+10.78K
+3.99%
Jun 20, 2025
Geode Capital Management, L.L.C.
259.15K
0.72%
+732.00
+0.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
249.82K
0.69%
+2.96K
+1.20%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Dyadic International Inc?
The top five shareholders of Dyadic International Inc are:
Emalfarb (Mark A) holds 4.73M shares, accounting for 13.07% of the total shares.
Francisco Trust holds 3.41M shares, accounting for 9.42% of the total shares.
Chapin Davis Asset Management holds 882.85K shares, accounting for 2.44% of the total shares.
The Vanguard Group, Inc. holds 860.66K shares, accounting for 2.38% of the total shares.
Truist Bank holds 250.00K shares, accounting for 0.69% of the total shares.
Emalfarb (Mark A) holds 4.73M shares, accounting for 13.07% of the total shares.
Francisco Trust holds 3.41M shares, accounting for 9.42% of the total shares.
Chapin Davis Asset Management holds 882.85K shares, accounting for 2.44% of the total shares.
The Vanguard Group, Inc. holds 860.66K shares, accounting for 2.38% of the total shares.
Truist Bank holds 250.00K shares, accounting for 0.69% of the total shares.
What are the top three shareholder types of Dyadic International Inc?
The top three shareholder types of Dyadic International Inc are:
Emalfarb (Mark A)
Francisco Trust
Apis Capital Advisors LLC
Emalfarb (Mark A)
Francisco Trust
Apis Capital Advisors LLC
How many institutions hold shares of Dyadic International Inc (DYAI)?
As of 2025Q4, 67 institutions hold shares of Dyadic International Inc, with a combined market value of approximately 6.19M, accounting for 14.14% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.07%.
What is the biggest source of revenue for Dyadic International Inc?
In --, the -- business generated the highest revenue for Dyadic International Inc, amounting to -- and accounting for --% of total revenue.
